48m ‘hoarded’ Panadol tablets confiscated from warehouse in Karachi’s Hawkesbay: Sindh govt

Published September 15, 2022
This image shows medicines seized from a warehouse in Karachi’s Hawkesbay on Thursday. — Photo by Murtaza Wahab/Twitter
This image shows medicines seized from a warehouse in Karachi’s Hawkesbay on Thursday. — Photo by Murtaza Wahab/Twitter

The Sindh Health Department on Thursday raided a warehouse in Karachi’s Hawkesbay area and confiscated 48 million “hoarded” Panadol tablets, according to officials.

Provincial Drug Inspector Dilawar Ali Jiskani told Dawn.com that the warehouse was owned by GlaxoSmithKline Consumer Healthcare Ltd.

“The seized medicines were being hoarded to sell them at expensive rates in the market,” he alleged, adding that the price of the tablets was estimated to be Rs250 million.

Jiskani added that the police have initiated a probe into the incident.

The development was also confirmed by Karachi Administrator Murtaza Wahab who, in a tweet, said that Panadol tablets were being hoarded at a time when the medicine was important for treating patients.

“Good assertiveness shown by the administration. Legal action is being further taken,” he tweeted.

Panadol tablet is manufactured by GlaxoSmithKline and is the brand name of the Paracetamol drug. It’s an antipyretic drug that’s frequently used for fever and pain. Demand for the tablet has been high, particularly in the wake of the flooding and rising cases of dengue fever.

However, in a statement later in the day, GlaxoSmithKline confirmed that a raid was conducted at one of its warehouses but refuted claims of hoarding Panadol tablets.

“We firmly reject the claims related to hoarding Panadol intentionally to create shortage,” it said, clarifying that the stocks at the warehouse were intended to be released and distributed in the country in the “normal course of business”.

The statement said that the company was led with the purpose of delivering everyday health to humanity. “This has been shown through our commitment to the people of Pakistan throughout challenging times.”

“We continue to supply Panadol products in the country and have adjusted our production capacity to ensure some product availability, despite market obstacles,” it added.

In a press conference earlier this week, Federal Minister for National Health Services (NHS) Abdul Qadir Patel accused pharmaceutical companies of creating an artificial shortage of medicines, especially Paracetamol, and warned them none of their “blackmail” tactics would work on him.

“I would suggest the media should criticise the pharmaceutical companies rather than the government as companies have created an artificial shortage. Similarly, some politicians have been doing marketing of a pharmaceutical company and its brand rather than focusing on the issue of flood victims,” he said.

On the other hand, the Pakistan Pharmaceutical Manufacturers Association (PPMA) has said that the drug shortage had been caused by an exorbitant increase in production costs.

Opinion

A state of chaos

A state of chaos

The establishment’s increasingly intrusive role has further diminished the credibility of the political dispensation.

Editorial

Bulldozed bill
Updated 22 May, 2024

Bulldozed bill

Where once the party was championing the people and their voices, it is now devising new means to silence them.
Out of the abyss
22 May, 2024

Out of the abyss

ENFORCED disappearances remain a persistent blight on fundamental human rights in the country. Recent exchanges...
Holding Israel accountable
22 May, 2024

Holding Israel accountable

ALTHOUGH the International Criminal Court’s prosecutor wants arrest warrants to be issued for Israel’s prime...
Iranian tragedy
Updated 21 May, 2024

Iranian tragedy

Due to Iran’s regional and geopolitical influence, the world will be watching the power transition carefully.
Circular debt woes
21 May, 2024

Circular debt woes

THE alleged corruption and ineptitude of the country’s power bureaucracy is proving very costly. New official data...
Reproductive health
21 May, 2024

Reproductive health

IT is naïve to imagine that reproductive healthcare counts in Pakistan, where women from low-income groups and ...